240 related articles for article (PubMed ID: 36340167)
1. Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors.
Pérez-González A; Castañeda-Arriaga R; Guzmán-López EG; Hernández-Ayala LF; Galano A
ACS Omega; 2022 Nov; 7(43):38254-38268. PubMed ID: 36340167
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of Multifunctional Ferulic Acid Derivatives Aimed for Alzheimer's and Parkinson's Diseases.
Guzmán-López EG; Reina M; Hernández-Ayala LF; Galano A
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371986
[TBL] [Abstract][Full Text] [Related]
3. Quinoline Derivatives: Promising Antioxidants with Neuroprotective Potential.
Hernández-Ayala LF; Guzmán-López EG; Galano A
Antioxidants (Basel); 2023 Oct; 12(10):. PubMed ID: 37891932
[TBL] [Abstract][Full Text] [Related]
4. CADMA-Chem: A Computational Protocol Based on Chemical Properties Aimed to Design Multifunctional Antioxidants.
Guzman-Lopez EG; Reina M; Perez-Gonzalez A; Francisco-Marquez M; Hernandez-Ayala LF; Castañeda-Arriaga R; Galano A
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362034
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase.
Hitge R; Smit S; Petzer A; Petzer JP
Bioorg Med Chem Lett; 2020 Jun; 30(12):127188. PubMed ID: 32299731
[TBL] [Abstract][Full Text] [Related]
6. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
Engelbrecht I; Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of catechol O-methyltransferase and monoamine oxidase by tetralone and indanone derivatives substituted with the nitrocatechol moiety.
de Beer AD; Legoabe LJ; Petzer A; Petzer JP
Bioorg Chem; 2021 Sep; 114():105130. PubMed ID: 34225162
[TBL] [Abstract][Full Text] [Related]
8. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer's disease.
Sang Z; Song Q; Cao Z; Deng Y; Tan Z; Zhang L
Eur J Med Chem; 2021 Apr; 216():113310. PubMed ID: 33667847
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-assisted synthesis of novel chalcone, heterochalcone and bis-chalcone derivatives and the evaluation of their antioxidant properties and as acetylcholinesterase inhibitors.
Polo E; Ibarra-Arellano N; Prent-Peñaloza L; Morales-Bayuelo A; Henao J; Galdámez A; Gutiérrez M
Bioorg Chem; 2019 Sep; 90():103034. PubMed ID: 31280015
[TBL] [Abstract][Full Text] [Related]
13. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation.
Tian C; Qiang X; Song Q; Cao Z; Ye C; He Y; Deng Y; Zhang L
Bioorg Chem; 2020 Jan; 94():103477. PubMed ID: 31818478
[TBL] [Abstract][Full Text] [Related]
14. Combining in vitro and in silico approaches to evaluate the multifunctional profile of rosmarinic acid from Blechnum brasiliense on targets related to neurodegeneration.
Andrade JM; Dos Santos Passos C; Kieling Rubio MA; Mendonça JN; Lopes NP; Henriques AT
Chem Biol Interact; 2016 Jul; 254():135-45. PubMed ID: 27270453
[TBL] [Abstract][Full Text] [Related]
15. Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors.
Oh JM; Rangarajan TM; Chaudhary R; Singh RP; Singh M; Singh RP; Tondo AR; Gambacorta N; Nicolotti O; Mathew B; Kim H
Molecules; 2020 May; 25(10):. PubMed ID: 32443652
[TBL] [Abstract][Full Text] [Related]
16. Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.
Yang X; Qiang X; Li Y; Luo L; Xu R; Zheng Y; Cao Z; Tan Z; Deng Y
Bioorg Chem; 2017 Apr; 71():305-314. PubMed ID: 28267984
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Zhang P; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Oct; 180():238-252. PubMed ID: 31310916
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase.
Engelbrecht I; Petzer JP; Petzer A
Cent Nerv Syst Agents Med Chem; 2019; 19(2):133-145. PubMed ID: 31258092
[TBL] [Abstract][Full Text] [Related]
19. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties.
Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y
Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535
[TBL] [Abstract][Full Text] [Related]
20. Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations.
Kollar J; Frecer V
J Mol Graph Model; 2018 Oct; 85():97-110. PubMed ID: 30145395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
